Plasma homocysteine concentration and peripheral neuropathy in Parkinson's disease patients: A pilot study

被引：0
|
作者：
Nevrly, M.
Vranova, H.
Chovancova, Z.
Nestrasil, I.
Otruba, P.
Dufek, J.
Kanovsky, P.
机构：
来源：
PARKINSONISM & RELATED DISORDERS | 2007年 / 13卷
关键词：
D O I：
10.1016/S1353-8020(08)70433-4
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [31] Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in Alzheimer's disease patients and in Parkinson's disease patients
    Genedani, S
    Rasio, G
    Cortelli, P
    Antonelli, F
    Guidolin, D
    Galantucci, M
    Fuxe, K
    Agnati, LF
    NEUROTOXICITY RESEARCH, 2004, 6 (04) : 327 - 332
  • [32] Studies on homocysteine and dehydroepiandrosterone sulphate plasma levels in alzheimer’s disease patients and in Parkinson’s disease patients
    S. Genedani
    G. Rasio
    P. Cortelli
    F. Antonelli
    D. Guidolin
    M. Galantucci
    K. Fuxe
    L. F. Agnati
    Neurotoxicity Research, 2004, 6 : 327 - 332
  • [33] Serum B12, Homocysteine Levels, and their Effect on Peripheral Neuropathy in Parkinson's Disease: Indian Cohort
    Mathukumalli, Neeharika L.
    Kandadai, Mridula R.
    Shaik, Jabeen A.
    Kanikannan, Meena A.
    Borgohain, Rupam
    ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2020, 23 (01) : 48 - 53
  • [34] Calpain activity in plasma of patients with essential tremor and Parkinson's disease: a pilot study
    Muruzheva, Zamira M.
    Traktirov, Dmitry S.
    Zubov, Alexander S.
    Pestereva, Nina S.
    Tikhomirova, Maria S.
    Karpenko, Marina N.
    NEUROLOGICAL RESEARCH, 2021, 43 (04) : 314 - 320
  • [35] Effect of levodopa and entacapone treatment on plasma homocysteine level in Parkinson disease. A pilot study
    Nevrly, M.
    Vranova, H.
    Ressner, P.
    Nestrasil, I.
    Kanovsky, P.
    MOVEMENT DISORDERS, 2006, 21 : S545 - S545
  • [36] Pilot study: Peripheral biomarkers for diagnosing sporadic Parkinson's disease
    Grünblatt E.
    Zehetmayer S.
    Jacob C.P.
    Müller T.
    Jost W.H.
    Riederer P.
    Journal of Neural Transmission, 2010, 117 (12) : 1387 - 1393
  • [37] Usefulness of total neuropathy score revised as a screening tool of peripheral neuropathy in patients with Parkinson's disease
    Ko, P. W.
    Park, J. S.
    Kang, K.
    Lee, H. W.
    MOVEMENT DISORDERS, 2016, 31 : S128 - S128
  • [38] Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson's disease patients
    Müller, T
    Kuhn, W
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (06) : 447 - 450
  • [39] Tolcapone decreases plasma levels of S-adenosyl-L-homocysteine and homocysteine in treated Parkinson’s disease patients
    Thomas Müller
    Wilfried Kuhn
    European Journal of Clinical Pharmacology, 2006, 62 : 447 - 450
  • [40] Plasma homocysteine levels are associated with peripheral neuropathy in patients with type 2 diabetes
    Idzior-Walus, B
    Sieradzki, J
    Walus-Miarka, M
    Cieslik, G
    Wozniakiewicz, E
    DIABETES, 2005, 54 : A8 - A8
12345